The global immunoprotein diagnostic testing market size is estimated to reach USD 14.86 billion in 2030 and is projected to grow at a CAGR of 7.7% from 2024 to 2030. This growth can be attributed to the rising incidence of chronic diseases. According to American Heart Association’s 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for immunoprotein diagnostics is expected to rise in order to facilitate rapid diagnosis.
Immunoprotein Diagnostic Testing Market Report Highlights
- Infectious disease testing held largest market share in 2023 owing to the increasing prevalence of infectious diseases and high applications of immunoprotein tests
- Enzyme-based immunoassays dominated the market in 2023 due to their frequent usage and availability of large number of products that possess this technology
- Chemiluminescence assay is anticipated to witness highest growth over the forecast period due to its high sensitivity and specificity
- North America dominated the market in 2023 due to rising prevalence of cancer & increase in mortality due to cancer-related diseases and favorable healthcare reimbursement scenario in the U.S.
For More Details or Sample Copy please visit link @: Immunoprotein Diagnostic Testing Market Report
According to WHO, nearly 1.69 million deaths due to lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important to reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved to be highly effective in rapidly detecting chronic diseases.
Technological advancements in the field of immunoprotein diagnostics have led to introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.
List of major companies in the Immunoprotein Diagnostic Testing Market
- Agilent Technologies, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc.
- Aurora Biomed Inc.
- Tecan Trading AG
- Promega Corporation
- Charles River Laboratories
- Creative Biolabs.
For Customized reports or Special Pricing please visit @: Immunoprotein Diagnostic Testing Market Analysis Report
We have segmented the global immunoprotein diagnostic testing market report based on test, technology, material, fluid, application and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
#DiagnosticTesting #ImmunoDiagnostics #HealthcareInnovation #MedicalDevices #ClinicalDiagnostics #Immunoproteins #HealthTech #LaboratoryTesting #DiseaseDetection #BiomarkerDiscovery #MedicalResearch #HealthcareTrends #Immunology #PatientCare #DiagnosticAdvancements
